CSTL castlebiosciences.com: Rasio total nilai perusahaan marang pendapatan

Castle Biosciences is expanding its laboratory capacities and implementing robotics to accelerate analysis. The enterprise value-to-revenue multiple demonstrates the asset's market position. The business relies on cloud IT services and external logistics, creating an ecosystem of molecular tests for oncologists. Meanwhile, the value of 2090.47 reflects the metric's balance between the market price and the company's actual operating revenues.
Rincian metrik keuangan lan pasar Castle Biosciences, Inc. (CSTL)

For Castle Biosciences (CSTL), this indicator serves as a tool for assessing the market value of the business, accounting for net debt relative to sales volume. By analyzing changes in the EV/Sales ratio, an investor determines the degree of asset overvaluation while excluding the influence of capital structure. This metric measures the monetization efficiency of diagnostic services. Diversifying tests into new medical segments reduces dependence on Medicare rates, which ensures the stability of the company's fundamental indicators.